Fortress Biotech Ownership | Who Owns Fortress Biotech?


OverviewForecastRevenueFinancialsChartTranscripts

Fortress Biotech Ownership Summary


Fortress Biotech is owned by 7.48% institutional investors, 22.79% insiders, and 69.73% retail investors. Vanguard group is the largest institutional shareholder, holding 4.04% of FBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.10% of its assets in Fortress Biotech shares.

FBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockFortress Biotech7.48%22.79%69.73%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.80%11.85%52.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.10M4.04%$4.03M
Opaleye management1.04M3.73%$2.91M
Shikiar asset management305.47K1.09%$852.00K
Geode capital management290.25K1.04%$810.11K
Gsa capital partners llp254.13K0.91%$709.00K
Northern trust230.05K0.82%$641.85K
Sculptor capital lp208.90K0.78%$771.89K
Susquehanna group, llp210.75K0.76%$587.98K
Blackrock funding, inc. /de197.09K0.71%$549.87K
Two sigma investments, lp196.82K0.71%$549.14K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management1.04M0.38%$2.91M
Pvg asset management38.79K0.30%$141.96K
Shikiar asset management305.47K0.25%$852.00K
Sheets smith investment management73.14K0.18%$270.26K
Gsa capital partners llp254.13K0.04%$709.00K
Scientech research18.07K0.02%$66.78K
180 wealth advisors63.80K0.02%$178.00K
Bridgeway capital management182.37K0.01%$508.81K
Sculptor capital lp208.90K0.01%$771.89K
Two sigma securities24.74K0.01%$69.04K

Top Buyers

HolderShares% AssetsChange
Gsa capital partners llp254.13K0.04%218.06K
Sculptor capital lp208.90K0.01%208.90K
Citadel advisors180.29K0.00%180.29K
Vanguard group1.10M0.00%150.24K
Vanguard fiduciary trust142.53K0.00%142.53K

Top Sellers

HolderShares% AssetsChange
Cambridge investment research advisors---1.00M
Summit financial20.66K0.00%-419.27K
Nantahala capital management---325.52K
B. riley wealth advisors---144.70K
Atria investments---88.81K

New Positions

HolderShares% AssetsChangeValue
Sculptor capital lp208.90K0.01%208.90K$771.89K
Citadel advisors180.29K0.00%180.29K$503.01K
Vanguard fiduciary trust142.53K0.00%142.53K$397.67K
Sheets smith investment management73.14K0.18%73.14K$270.26K
Cubist systematic strategies20.93K0.00%20.93K$77.35K

Sold Out

HolderChange
Sbi securities-1.00
Raymond james financial-26.00
Swan capital-250.00
Toth financial advisory-400.00
Citigroup-525.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202619-66.07%2,086,461-63.88%71.66%9-67.86%4-73.33%
Dec 31, 202514-77.78%1,789,594-59.94%62.38%5-86.84%3-76.92%
Sep 30, 202514-73.08%1,602,201-67.70%51.69%8-70.37%4-69.23%
Jun 30, 2025514.08%4,637,257-5.60%175.08%2728.57%12-
Mar 31, 202548-12.73%4,440,118-7.34%163.16%20-39.39%129.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv697.80K2.10%-
Vanguard US Total Market Shares ETF470.54K1.59%-
Vanguard Institutional Extnd Mkt Idx Tr280.86K0.85%31.92K
Bridgeway Ultra-Small Company182.37K0.55%-
Fidelity Extended Market Index132.06K0.40%1.67K
Extended Equity Market Fund B66.56K0.21%-
Extended Equity Market Fund E66.56K0.21%-
Blackrock Extended Mkt Fund CF66.56K0.20%-
iShares Micro-Cap ETF62.14K0.19%-
Extended Equity Market Fund K56.68K0.18%-415.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Sep 23, 2024ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMANBuy$1.40M
Jul 11, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$37.42K
Jul 10, 2024Jin David Chief Financial OfficerBuy$3.75K
Jul 09, 2024ROSENWALD LINDSAY A MD President, CEO & ChairmanBuy$36.97K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--

FBIO Ownership FAQ


Who Owns Fortress Biotech?

Fortress Biotech shareholders are primarily institutional investors at 7.48%, followed by 22.79% insiders and 69.73% retail investors. The average institutional ownership in Fortress Biotech's industry, Biotech Stocks , is 35.80%, which Fortress Biotech falls below.

Who owns the most shares of Fortress Biotech?

Fortress Biotech’s largest shareholders are Vanguard group (1.1M shares, 4.04%), Opaleye management (1.04M shares, 3.73%), and Shikiar asset management (305.47K shares, 1.09%). Together, they hold 8.87% of Fortress Biotech’s total shares outstanding.

Does Blackrock own Fortress Biotech?

BlackRock is not among the top 10 institutional shareholders of Fortress Biotech.

Who is Fortress Biotech’s biggest shareholder by percentage of total assets invested?

Opaleye management is Fortress Biotech’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 1.04M Fortress Biotech shares, valued at 2.91M$.

Who is the top mutual fund holder of Fortress Biotech shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Fortress Biotech shares, with 2.10% of its total shares outstanding invested in 697.8K Fortress Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools